Biogen Inc Drug Patent Portfolio

Biogen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Biogen Inc News

Biogen Launches New Venture at JP Morgan 2026 | PharmExec

13 Jan, 2026

Lessons from Cancer Treatment Applied to Alzheimer's: A Multi-Target Drug Approach - OC Academy

12 Dec, 2025

Alzheimer's medication research draws inspiration from cancer treatment strategies that focus on multiple targets - The Japan Times

12 Dec, 2025

Biogen and Stoke Enhance the Promising Market Potential of Their Epilepsy Medication with Initial Findings on Seizure Reduction

08 Dec, 2025

See More